Evidence | Harmful sexual behaviour among children and young people | Guidance | NICE

Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
HealthTech Connect is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Evidence

Review and download supporting evidence. Includes the full guideline if available.

Supporting evidence

Evidence review
Evidence review 1 - Interventions ^{PDF 2.14 MB} 20 September 2016
Evidence review 2 - Assessment ^{PDF 1.55 MB} 20 September 2016
Expert reports
Expert paper 1 - Definitions, epidemiology and natural history of HSB ^{PDF 131 KB} 20 September 2016
Expert paper 2 - Children and young people with troubling behaviours/personality disorders who display harmful sexual behaviour ^{PDF 148 KB} 20 September 2016
Expert paper 3 - Evidence of effective interventions for children 10 and under ^{PDF 141 KB} 20 September 2016
Expert paper 4 - The development of standardised assessment tools and intervention resources for girls who have engaged in harmful sexual behaviour (Barnardo’s) ^{PDF 155 KB} 20 September 2016
Expert paper 5 - The development of standardised assessment tools and intervention resources for girls who have engaged in harmful sexual behaviour (Glebe House) ^{PDF 152 KB} 20 September 2016
Expert paper 6 - Presentation of preliminary results of evaluation study into harmful sexual behaviour ^{PDF 230 KB} 20 September 2016
Expert paper 7 - Children and young people with learning difficulties who display harmful sexual behaviour ^{PDF 207 KB} 20 September 2016
Expert paper 8 - AIM project ^{PDF 143 KB} 20 September 2016
Expert paper 9 - Service user perspective of HSB services ^{PDF 141 KB} 20 September 2016
Expert paper 10 - Expert testimony from advocate for children and young people displaying harmful sexual behaviour ^{PDF 162 KB} 20 September 2016
Expert paper 11 - Emerging findings from research on the impact of pornography on children and young people and the difficulties of doing research in this area. If it is too early to discuss emerging findings is it possible to discuss what is currently known in this area? ^{PDF 145 KB} 20 September 2016
Expert paper 12 - National Operational Framework for work with children and young people who display harmful sexual behaviour ^{PDF 73 KB} 20 September 2016
Expert paper 13 - An overview of policies and procedures across the devolved administrations including the role of primary prevention. What are the elements of a good service response to the issue of harmful sexual behaviour among children and young people ^{PDF 126 KB} 20 September 2016
Expert paper 14 - MST-PSB ^{PDF 131 KB} 20 September 2016